Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia

Overview of attention for article published in Journal of Molecular Medicine, October 2009

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 116 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 36,716 followers.

En pacientes con caquexia por cáncer, el celecoxib produjo aumento significativo de la masa magra y la fuerza https://t.co/6N0FUZijmj

Reply Repost Favourite